Free Trial

Morgan Stanley Raises Houlihan Lokey (NYSE:HLI) Price Target to $192.00

Houlihan Lokey logo with Finance background

Houlihan Lokey (NYSE:HLI - Get Free Report) had its price target increased by equities research analysts at Morgan Stanley from $159.00 to $192.00 in a research note issued on Monday,Benzinga reports. The firm presently has an "overweight" rating on the financial services provider's stock. Morgan Stanley's price objective points to a potential upside of 9.31% from the stock's previous close.

A number of other research firms also recently issued reports on HLI. Keefe, Bruyette & Woods upped their price target on shares of Houlihan Lokey from $183.00 to $185.00 and gave the company a "market perform" rating in a research note on Monday, May 12th. Wells Fargo & Company upped their target price on shares of Houlihan Lokey from $170.00 to $185.00 and gave the company an "overweight" rating in a research report on Thursday, May 8th. Finally, Wall Street Zen raised shares of Houlihan Lokey from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $192.20.

View Our Latest Research Report on HLI

Houlihan Lokey Stock Up 1.5%

HLI stock traded up $2.67 during trading on Monday, reaching $175.65. The company's stock had a trading volume of 24,924 shares, compared to its average volume of 349,971. The company's fifty day moving average is $169.19 and its 200-day moving average is $170.04. The company has a market capitalization of $12.26 billion, a P/E ratio of 30.17 and a beta of 0.83. Houlihan Lokey has a 1 year low of $129.32 and a 1 year high of $192.10.

Houlihan Lokey (NYSE:HLI - Get Free Report) last issued its earnings results on Wednesday, May 7th. The financial services provider reported $1.96 earnings per share for the quarter, topping analysts' consensus estimates of $1.61 by $0.35. Houlihan Lokey had a net margin of 16.73% and a return on equity of 21.61%. The firm had revenue of $666.42 million during the quarter, compared to analyst estimates of $628.25 million. During the same quarter in the prior year, the business earned $1.27 earnings per share. Houlihan Lokey's revenue for the quarter was up 28.0% on a year-over-year basis. Analysts anticipate that Houlihan Lokey will post 5.98 earnings per share for the current year.

Insider Activity at Houlihan Lokey

In related news, General Counsel Christopher M. Crain sold 500 shares of the business's stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $173.02, for a total value of $86,510.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Scott L. Beiser sold 8,008 shares of the firm's stock in a transaction on Monday, May 19th. The stock was sold at an average price of $178.71, for a total value of $1,431,109.68. The disclosure for this sale can be found here. 23.68% of the stock is owned by company insiders.

Institutional Trading of Houlihan Lokey

Institutional investors and hedge funds have recently made changes to their positions in the company. CIBC Asset Management Inc raised its stake in Houlihan Lokey by 5.0% in the fourth quarter. CIBC Asset Management Inc now owns 1,617 shares of the financial services provider's stock worth $281,000 after buying an additional 77 shares in the last quarter. Atria Wealth Solutions Inc. raised its position in shares of Houlihan Lokey by 6.2% in the 4th quarter. Atria Wealth Solutions Inc. now owns 1,625 shares of the financial services provider's stock worth $282,000 after acquiring an additional 95 shares in the last quarter. Private Advisor Group LLC lifted its stake in shares of Houlihan Lokey by 51.8% during the 4th quarter. Private Advisor Group LLC now owns 5,664 shares of the financial services provider's stock worth $984,000 after purchasing an additional 1,934 shares during the last quarter. Handelsbanken Fonder AB lifted its stake in shares of Houlihan Lokey by 10.7% during the 4th quarter. Handelsbanken Fonder AB now owns 13,458 shares of the financial services provider's stock worth $2,337,000 after purchasing an additional 1,300 shares during the last quarter. Finally, Union Bancaire Privee UBP SA bought a new stake in Houlihan Lokey during the fourth quarter valued at about $1,657,000. 78.07% of the stock is currently owned by institutional investors.

About Houlihan Lokey

(Get Free Report)

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.

Read More

Analyst Recommendations for Houlihan Lokey (NYSE:HLI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Houlihan Lokey Right Now?

Before you consider Houlihan Lokey, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.

While Houlihan Lokey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines